Document is current
Any future updates will be listed below
-
Authors
Zhang, Yajuan
Li, Yanlin
Zhang, Yamin
Zhang, Tian
Li, Miao
Yu, Xin
Wang, Tongfei
Feng, Xiemin
Xu, Rui
Xia, Weihu
Xu, Hong
Song, Xiaojie
Zhao, Yaning
Hou, Xinli
Wei, Hui
Liu, Zhiyan
Zan, Ying
Zhao, Bing
Liu, Chunling
He, Xiaopeng
Liang, Xuan
Jiao, Min
Wang, Wenjuan
Wang, Duolao
Jiang, Lili
Mi, Baibing
Bai, Yixue
Huang, Xubo
Jia, Xiaohui
Fu, Xiaolan
Shen, Yuan
Guo, Hui
Liu, Mengjie
-
Funding
Funding for this research was provided by:
The Clinical Research Award of the First Affiliated Hospital of Xi’an Jiaotong University (XJTU1AF-CRF-2022-020)
Science and Technology Program of Shaanxi Province (2022JQ-784)
Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG) and Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2017B0303141020)
Fundamental Research Funds for Central Universities, Interdisciplinary Team of Tumor Immunotherapy and Physical Microenvironment (xtr062021001)
- License Information
-
More Information
Article History
Received: 31 March 2024
Accepted: 14 August 2025
First Online: 26 September 2025
Declarations
:
: This study was approved by the Ethics Committee of First Affiliated Hospital of Xi’an Jiaotong University (No.XJTU1AF2022LSL-020) on 23 November, 2022. Authors ensure that all procedures were performed in compliance with relevant laws and institutional guidelines. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare no competing interests.
